HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Hasan Selected Research

Treatment-Resistant Schizophrenia

1/2022Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders.
10/2018Clozapine as a first- or second-line treatment in schizophrenia: a systematic review and meta-analysis.
8/2013[Treatment-resistant schizophrenia - biological treatments].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Hasan Research Topics

Disease

17Schizophrenia (Dementia Praecox)
01/2022 - 11/2009
3COVID-19
05/2022 - 06/2021
3Treatment-Resistant Schizophrenia
01/2022 - 08/2013
3Psychotic Disorders (Schizoaffective Disorder)
10/2018 - 08/2014
2Liver Cirrhosis (Hepatic Cirrhosis)
09/2022 - 02/2019
2Inflammation (Inflammations)
09/2021 - 07/2015
2Brain Diseases (Brain Disorder)
05/2018 - 01/2013
2Neoplasms (Cancer)
11/2015 - 01/2011
2Congenital Heart Defects (Congenital Heart Defect)
08/2010 - 04/2005
2Infections
03/2009 - 07/2000
2Pulmonary Hypertension
10/2003 - 01/2000
1Fibrosis (Cirrhosis)
09/2022
1Genetic Risk Score
01/2022
1Aortic Valve Insufficiency (Aortic Regurgitation)
11/2021
1Diarrhea
09/2021
1Major Depressive Disorder (Major Depressive Disorders)
09/2021
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
09/2021
1Cardiovascular Diseases (Cardiovascular Disease)
01/2020
1Cognitive Dysfunction
12/2018
1Seizures (Absence Seizure)
05/2018
1Autoimmune Diseases of the Nervous System
05/2018
1Stroke (Strokes)
01/2018
1Tooth Wear
01/2018
1Ischemic Stroke
01/2018
1Personality Disorders (Personality Disorder)
08/2016
1Psychotic Affective Disorders
08/2016
1Wilms Tumor (Wilm's Tumor)
11/2015
1Leukemia
11/2015
1Lymphoma (Lymphomas)
11/2015
1Asthma (Bronchial Asthma)
07/2015
1Mood Disorders (Mood Disorder)
03/2015
1Hepatitis
01/2013

Drug/Important Bio-Agent (IBA)

5Antipsychotic Agents (Antipsychotics)IBA
01/2022 - 11/2009
4Pharmaceutical PreparationsIBA
09/2022 - 08/2016
4AntibodiesIBA
05/2018 - 08/2003
3AntioxidantsIBA
09/2022 - 01/2012
3Clozapine (Clozaril)FDA LinkGeneric
01/2022 - 11/2016
3Proteins (Proteins, Gene)FDA Link
12/2021 - 11/2015
3Heat-Shock Proteins (Heat-Shock Protein)IBA
12/2005 - 05/2002
2EnzymesIBA
09/2022 - 01/2022
2PhytochemicalsIBA
12/2021 - 06/2021
2Antidepressive Agents (Antidepressants)IBA
09/2021 - 06/2010
2salicylhydroxamic acid (SHAM)IBA
01/2017 - 11/2009
2Peptides (Polypeptides)IBA
11/2015 - 01/2003
2T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
11/2015 - 05/2002
2Oxidants (Oxidizing Agents)IBA
07/2015 - 01/2012
2Glutamic Acid (Glutamate)FDA Link
03/2015 - 08/2014
2Dopamine (Intropin)FDA LinkGeneric
08/2014 - 01/2013
2Biological ProductsIBA
08/2013 - 06/2012
1Olive OilIBA
09/2022
1SilymarinIBA
09/2022
1Metformin (Glucophage)FDA LinkGeneric
09/2022
1Eosine Yellowish-(YS) (Eosin)IBA
09/2022
1Hematoxylin (Haematoxylon)IBA
09/2022
1Carbon Tetrachloride (Tetrachloromethane)IBA
09/2022
1Coloring Agents (Dyes)IBA
09/2022
1Transforming Growth Factor beta (TGF-beta)IBA
09/2022
1Cytochrome P-450 CYP2C19IBA
01/2022
1Cytochrome P-450 CYP2D6 (CYP2D6)IBA
01/2022
1Cytochrome P-450 CYP1A2 (CYP1A2)IBA
01/2022
1Dibutyl Phthalate (Butyl Phthalate)IBA
12/2021
1Hypoglycemic Agents (Hypoglycemics)IBA
12/2021
1nerolidolIBA
12/2021
1Antimalarials (Antimalarial Agents)IBA
12/2021
1Complex MixturesIBA
12/2021
1Dihydrotachysterol (AT 10)IBA
11/2021
1Angiotensin-Converting Enzyme 2IBA
09/2021
1FlavonoidsIBA
09/2021
1Peptide Hydrolases (Proteases)FDA Link
06/2021
1VaccinesIBA
06/2021
1AngiotensinsIBA
06/2021
1AutoantibodiesIBA
05/2018
1AcidsIBA
01/2018
1Tissue Plasminogen Activator (Alteplase)FDA Link
01/2018
1EpitopesIBA
11/2015
1RMFPNAPYLIBA
11/2015
1Indicators and Reagents (Reagents)IBA
11/2015
1Chimeric Antigen ReceptorsIBA
11/2015
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/2015
1HLA-A2 Antigen (HLA A2 Antigen)IBA
11/2015
1Biomarkers (Surrogate Marker)IBA
07/2015
1Aryldialkylphosphatase (Paraoxonase)IBA
07/2015
1Transcription Factor 4IBA
06/2015
1Diacylglycerol KinaseIBA
03/2015
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
08/2014
1N-Methylaspartate (NMDA)IBA
01/2013
1GABA Receptors (GABA Receptor)IBA
01/2013
1Intravenous Immunoglobulins (IVIG)FDA Link
01/2013
1Cidofovir (Vistide)FDA Link
01/2013
1DNA-Directed DNA Polymerase (Polymerases, DNA)IBA
01/2013

Therapy/Procedure

5Therapeutics
12/2021 - 03/2009
3Transcranial Magnetic Stimulation
01/2017 - 11/2009
2Transcranial Direct Current Stimulation
09/2021 - 12/2018
2Liver Transplantation
02/2019 - 01/2013
2Secondary Prevention
01/2016 - 09/2014
2Heart Transplantation (Grafting, Heart)
08/2010 - 07/2000
1Intraperitoneal Injections
09/2022
1Resistance Training
01/2020
1Cognitive Training
12/2018
1Endurance Training
01/2017